Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Statistics

Total Valuation

AMLX has a market cap or net worth of $1.56 billion. The enterprise value is $1.21 billion.

Market Cap	1.56B
Enterprise Value	1.21B

Important Dates

The last earnings date was Tuesday, March 3, 2026, before market open.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

AMLX has 110.54 million shares outstanding. The number of shares has increased by 38.78% in one year.

Current Share Class	110.54M
Shares Outstanding	110.54M
Shares Change (YoY)	+38.78%
Shares Change (QoQ)	+17.69%
Owned by Insiders (%)	6.75%
Owned by Institutions (%)	85.57%
Float	82.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.96
P/TBV Ratio	4.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.27, with a Debt / Equity ratio of 0.02.

Current Ratio	14.27
Quick Ratio	13.98
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.59% and return on invested capital (ROIC) is -40.09%.

Return on Equity (ROE)	-61.59%
Return on Assets (ROA)	-36.41%
Return on Invested Capital (ROIC)	-40.09%
Return on Capital Employed (ROCE)	-49.46%
Weighted Average Cost of Capital (WACC)	2.58%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	136
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AMLX has paid $46,000 in taxes.

Income Tax	46,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +277.75% in the last 52 weeks. The beta is -0.30, so AMLX's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	+277.75%
50-Day Moving Average	14.30
200-Day Moving Average	11.63
Relative Strength Index (RSI)	44.94
Average Volume (20 Days)	942,214

Short Selling Information

The latest short interest is 14.50 million, so 13.12% of the outstanding shares have been sold short.

Short Interest	14.50M
Short Previous Month	14.31M
Short % of Shares Out	13.12%
Short % of Float	17.49%
Short Ratio (days to cover)	15.10

Income Statement

Revenue	n/a
Gross Profit	-90.40M
Operating Income	-153.29M
Pretax Income	-144.69M
Net Income	-144.74M
EBITDA	-152.77M
EBIT	-153.29M
Earnings Per Share (EPS)	-$1.53

Balance Sheet

The company has $316.98 million in cash and $5.96 million in debt, with a net cash position of $311.02 million or $2.81 per share.

Cash & Cash Equivalents	316.98M
Total Debt	5.96M
Net Cash	311.02M
Net Cash Per Share	$2.81
Equity (Book Value)	305.26M
Book Value Per Share	2.78
Working Capital	300.98M

Cash Flow

In the last 12 months, operating cash flow was -$123.34 million and capital expenditures -$138,000, giving a free cash flow of -$123.48 million.

Operating Cash Flow	-123.34M
Capital Expenditures	-138,000
Free Cash Flow	-123.48M
FCF Per Share	-$1.12

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AMLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.78%
Shareholder Yield	-38.78%
Earnings Yield	-9.51%
FCF Yield	-8.11%

Analyst Forecast

The average price target for AMLX is $20.11, which is 42.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.11
Price Target Difference	42.73%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2